JUN 13, 2019 11:44 AM PDT

Proton Therapy May Reduce Second Cancer Risk More Than Other Radiation Types

WRITTEN BY: Julia Travers

A new study finds that proton beam radiation therapy (PBRT) might lead to a reduction in the risk for a second cancer, when compared to other types of contemporary radiation therapy. The researchers analyzed National Cancer Database (NCDB) data on adult and pediatric patients with cancer. It used the data to determine the second-cancer risk associated with three types of radiation therapy (RT):  PBRT, intensity-modulated radiation therapy (IMRT) and three-dimensional conformal radiation therapy (3DCRT). The therapies included were administered between 2004 and 2016 to patients of diverse ages, and those with metastatic disease were not included.

PBRT, credit: public domain

PBRT Study Design and Findings

Head and/or neck, breast, gastrointestinal, gynecologic, non–small cell lung, prostate, bone/soft tissue, lymphoma and brain/central nervous system tumors were included. The total number of patients whose data were analyzed was 450,373. The percentage of people who also received chemotherapy was higher in the 3DCRT group, at 48 percent, and lower in the IMRT and PBRT groups, which were at 38 and 17 percent, respectively. PBRT was used most with prostate tumors. Head and neck cancers were treated primarily with IMRT, and 3DCRT was utilized most often for breast cancers.

The crude absolute incidence rate of subsequent cancer diagnosis per 100 patient-years was 1.60 in the 3DCRT cohort, 1.55 in the IMRT cohort, and 0.44 in the PBRT cohort.

PBRT Study Conclusions and Limitations

“Patients most likely to benefit from PBRT may be [children] and young adults due to the potential for a long life expectancy and increased susceptibility to treatment-related malignancies,” Michael Xiang, M.D., Ph.D., of Stanford University, said.

Some of the study’s constraints were tied to the NCDB, which does not allow researchers to discern the location of a second cancer relative to an RT field. The database also does not account for risk factors like obesity or smoking, among other limitations.

To learn the basics of how proton therapy treats cancer, check out the video below.

Source: ASCO News

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
MAR 29, 2020
Cancer
MAR 29, 2020
Improving ependymoma diagnostics
Have you ever heard of ependymoma? This rare form of brain cancer most commonly occurs in young children when tumors for ...
APR 04, 2020
Cancer
APR 04, 2020
Unique Cancer Mutation Hijacks Nearby Signaling Pathway
  In cancer, tyrosine kinase mutations are quite common. MET is one such example that normally binds its native lig ...
APR 09, 2020
Cancer
APR 09, 2020
Adjuvant immunotherapy proves effective for colon cancer
Results from a study published in Nature Medicine highlights the benefits of receiving pre-surgery immunotherapy for som ...
APR 14, 2020
Clinical & Molecular DX
APR 14, 2020
Urchin-shaped DNA Biosensor Detects Disease Earlier
For researchers at the Missouri University of Science and Technology developing a new class of nanodiagnostics, good thi ...
APR 21, 2020
Clinical & Molecular DX
APR 21, 2020
Skin Deep: Handheld Device Sees the Earliest Signs of Cancer
Researchers have developed a handheld device that can image structures under the skin at resolutions 100 times greater t ...
APR 22, 2020
Cancer
APR 22, 2020
This model predicts those at high risk of pancreatic cancer
A new study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Can ...
Loading Comments...